CapsoVision, Inc Selling and Marketing Expense
CapsoVision, Inc (CV) reported Selling and Marketing Expense of $1.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-13
- CapsoVision, Inc selling and marketing expense for the quarter ending 2026-06-30 was $1.94M, a 4.82% increase year-over-year.
- CapsoVision, Inc selling and marketing expense for the quarter ending 2026-03-31 was $2.09M, a 6.63% increase year-over-year.
- CapsoVision, Inc selling and marketing expense for the quarter ending 2025-12-31 was $1.95M, a 8.34% increase year-over-year.
- CapsoVision, Inc selling and marketing expense for the quarter ending 2025-09-30 was $1.77M, a 1.60% increase year-over-year.
- CapsoVision, Inc selling and marketing expense for fiscal 2025 was $7.53M, a 8.08% increase from fiscal 2024.
- CapsoVision, Inc selling and marketing expense for fiscal 2024 was $6.97M.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.94M 10-Q · filed 2026-08-13 | $4.03M 10-Q · filed 2026-08-13 | $5.98M derived: sum of 3 quarters · filed 2026-08-13 | $7.75M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.09M 10-Q · filed 2026-05-14 | $4.04M derived: sum of 2 quarters · filed 2026-05-14 | $5.81M derived: sum of 3 quarters · filed 2026-05-14 | $7.66M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $3.72M derived: sum of 2 quarters · filed 2026-03-26 | $5.57M derived: sum of 3 quarters · filed 2026-08-13 | $7.53M 10-K · filed 2026-03-26 |
| 2025-09-30 | $1.77M 10-Q · filed 2025-11-13 | $3.62M derived: sum of 2 quarters · filed 2026-08-13 | $5.58M 10-Q · filed 2025-11-13 | $7.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.85M 10-Q · filed 2026-08-13 | $3.81M 10-Q · filed 2026-08-13 | $5.61M derived: sum of 3 quarters · filed 2026-08-13 | $7.35M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.96M 10-Q · filed 2026-05-14 | $3.76M derived: sum of 2 quarters · filed 2026-05-14 | $5.50M derived: sum of 3 quarters · filed 2026-05-14 | $7.29M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $3.54M derived: sum of 2 quarters · filed 2026-03-26 | $5.33M derived: sum of 3 quarters · filed 2026-03-26 | $6.97M 10-K · filed 2026-03-26 |
| 2024-09-30 | $1.75M 10-Q · filed 2025-11-13 | $3.53M derived: sum of 2 quarters · filed 2025-11-13 | $5.17M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.78M 10-Q · filed 2025-08-14 | $3.42M 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |